Blood glucose meter

DEVICE5 trials

Sponsors

Ascensia Diabetes Care, DexCom, Inc., Senseonics, Inc., Seoul National University Hospital, Astellas Pharma Inc

Conditions

DiabetesDiabetes Mellitus, Type 2Lifestyle Risk ReductionType 2 Diabetes Mellitus

Unknown Phase

Blood Glucose Testing and You

CompletedNCT01453413

Ascensia Diabetes CareDiabetes

Start: 2011-10-31End: 2011-11-30Updated: 2013-02-25

Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)

CompletedNCT03566693

DexCom, Inc.Diabetes Mellitus, Type 2

Start: 2018-07-30End: 2021-01-04Updated: 2021-04-21

Eversense® Non-adjunctive Use Post Approval Study

Active, not recruitingNCT04836546

Senseonics, Inc.Diabetes

Start: 2021-04-13End: 2026-03-31Target: 925Updated: 2025-08-13

Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients

RecruitingNCT04932928

Seoul National University HospitalDiabetes Mellitus, Type 2, Lifestyle Risk Reduction

Start: 2021-03-23End: 2023-03-23Target: 126Updated: 2021-06-21

A Study to Compare the Use of Diabetes Treatment Support System (BAP0527 and Blood Glucose Meter) in Addition to Daily Practice and Treatment With Daily Practice and Treatment Alone in Patients With Type 2 Diabetes Mellitus

CompletedNCT06156696

Astellas Pharma IncType 2 Diabetes Mellitus

Start: 2024-02-16End: 2025-09-10Updated: 2026-09-30

Related Papers

Rapid improvements in glycemic management with use of continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin: 3-month analysis of the MOBILE study.

2025-11-04

Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin: A Randomized Clinical Trial

UNC Libraries2024-05-2245 citations

Magnitude of Glycemic Improvement in Patients with Type 2 Diabetes Treated with Basal Insulin: Subgroup Analyses from the MOBILE Study

Diabetes Technology & Therapeutics2021-12-2827 citations

With or Without Residual C-Peptide, Patients with Type 2 Diabetes Realize Glycemic Benefits from Real-Time Continuous Glucose Monitoring

Diabetes Technology & Therapeutics2021-10-273 citations

Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin

JAMA2021-06-03442 citations

Testing versus guessing blood glucose values: impact on self-care behaviors in type 2 diabetes.

2014-06-302 citations